AB Science: 2012 Annual Financial Results and 2013 First Quarter Revenue
Apr 29, 2013 | istockanalyst.com
Filing to the European Medicines Agency of two conditional Marketing Authorization Applications in oncology AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specialized in research, development and...
Read more...
masitinib AB EUR Science thousand GIST Gemzar patient 31 nominal euro December